Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Related studies linked through entity extraction aliases.